Inventor

Matthias Urmann

Inventor
Frankfurt am Main, DE

Overview

32→
Patents
2006–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 32 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations34%
A61KPreparations for medical, dental or toiletry purposes20%
C07KPeptides3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07BGeneral methods of organic chemistry1%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
8,946,212'Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals'20158,748,483'Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome'20148,735,586'Regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles'20148,716,317'Sulfonamides with heterocycle and oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals'20148,487,109'Process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates'20138,420,812'Process for the palladium-catalyzed coupling of terminal alkynes with heteroaryl tosylates and heteroaryl benzenesulfonates'20138,344,004'Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals'20138,329,725'Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals'20128,283,476'Transition metal catalyzed synthesis of 2H-indazoles'20128,188,282'Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles'20128,173,674'Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals'20128,088,925'Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors'20128,026,375'Transition metal catalyzed synthesis of N-aminoindoles'20117,910,612'4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use'20117,858,647'N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use'20107,851,493'Phenyl-1,2,4-oxadiazolone derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals'20107,834,030'Phenyl-[1,2,4]-oxadiazol-5-one derivatives, pharmaceutical compositions and therapeutic use thereof'20107,772,252'Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands'20107,772,257'Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use'20107,741,341'Benzimidazole-derivatives as factor Xa inhibitors'20107,709,481'Phenyl-1,2,4-oxadiazolone derivatives, processes for their preparation and methods for their use as pharmaceuticals'20107,683,181'Cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof'20107,655,679'Derivatives of 2-aminothiazoles and 2-amino-oxazoles, processes for their preparation and their use as pharmaceutical compositions'20107,612,104'Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use'20097,550,469'Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands'20097,521,445'Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands'20097,465,806'Pyrrole-derivatives as factor Xa inhibitors'20087,449,560'Phosophoinositoglycan binding proteins'20087,365,088'Indazole-derivatives as factor Xa inhibitors'20087,317,027'Azaindole-derivatives as factor Xa inhibitors'20087,186,724'Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands'20077,049,416'Phosophoinositoglycan binding proteins'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2010Patents assigned to SANOFI AVENTIS DEUTSCHLAND (6)· patent assignee history
2006–2011Based in Eschborn, DE· patent location history
2009–2015Patents assigned to SANOFI AVENTIS (14)· patent assignee history
2009–2015Based in Frankfurt am Main, DE· patent location history
2012–2015Patents assigned to URMANN MATTHIAS (12)· patent assignee history
2012–2014Patents assigned to SANOFI SA (8)· patent assignee history
2012–2014Patents assigned to ALONSO JORGE (5)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANOFI AVENTIS142009–2015
URMANN MATTHIASself122012–2015
SANOFI SA82012–2014
SANOFI AVENTIS DEUTSCHLAND62006–2010
ALONSO JORGE52012–2014
Locations
LocationPatentsSpan
Frankfurt am Main, DE192009–2015
Eschborn, DE132006–2011